Dynavax Technologies
DVAX Small CapHealthcare · Drug Manufacturers - Specialty & Generic
Aggiornato: May 2, 2026, 22:05 UTC
Metriche Chiave
Analisi della Valutazione
Informazioni sull'Azienda
Dynavax Technologies Stock at a Glance
Dynavax Technologies (DVAX) is currently trading at 13,22 € with a market capitalization of 1,6 Mrd. €. The 52-week range spans from 0,00 € to 13,42 €; the current price is 1.5% below the yearly high. Year-over-year revenue growth stands at +17.7%.
💰 Dividendo
Dynavax Technologies currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.
📊 Raccomandazioni degli Analisti
1 analysts rate Dynavax Technologies (DVAX) on consensus: Acquisto Forte. The average price target is 13,65 €, implying +3.23% from the current price. Analyst price targets range from 13,65 € to 13,65 €.
Tesi di Investimento: Punti di Forza e Debolezze
- High gross margin of 61.6% — indicates pricing power
- Analyst consensus: Strong Buy
- Positive free cash flow
- –Currently unprofitable
- –High short interest (13.19%)
Panoramica Tecnica
Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).
Profilo di Rischio
The data points to relatively defensive market behavior, elevated short interest (13.19%).
Dati di Trading
Azioni Correlate nello Stesso Settore
Where can I buy Dynavax Technologies?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
